Susan Hasty, Publisher
Table of Contents . . . November 10th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Medical Letter on the CDC and FDA | Other Publications
AIDS and HIV Therapy - Viral resistance to entry inhibitors limited
Obesity - Prevalence continues to increase among U.S. adults
Food-borne Illness - Consumers advised of risks associated with eating raw and lightly cooked sprouts
Influenza - African Americans less likely than Caucasians to be vaccinated against flu
Public Health - Food Code sets new standard for food service workers
Spina Bifida - CDC reports efforts to reduce birth defects successful
Anthrax - Franek Technologies advances bioterrorism preparedness
Anthrax - HHS announces contracts for developing new vaccine
Antibiotic Resistance - CDC approves partnership agreement with Quigley Corp.
Breast Cancer - OSU studies risk related to beef consumption
Cancer Therapy - Alfacell, NCI expand research collaboration
Hemorrhagic Fever - Emory microbiologists will study vaccines using NIH bioterrorism grant
Immunization - Medicare rule change sets new standards
Influenza - FDA approves preservative-free flu vaccine for pediatric use
Influenza - Vaccine shipments should arrive in time for high-risk patients
Malaria - Parasite, mosquito genomes complete malaria picture
Measles - Fears of an epidemic prompt urgent vaccination campaign in famine-hit Zimbabwe
Parkinson Disease - New study shows efficacy of gene therapy
Regulatory Issues - Strong warning labels urged for ephedra
Research Funding - FDA awards five contracts for women's studies, four of them for counterterrorism
Vertical Transmission - Efforts to fight mother-to-child HIV transmission making an impact
Weight Loss - FDA cracks down on ephedra product
West Nile Virus - EPA will bypass pesticide regulations to fight outbreaks
West Nile Virus - NASA researchers developing tools to help track and predict epidemiology
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.